US Patent Issued to JIANGSU VCARE PHARMATECH on May 20 for "Janus kinase (JAK) family inhibitor, preparation of same, and applications thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,910, issued on May 20, was assigned to JIANGSU VCARE PHARMATECH Co. LTD. (Jiangsu, China).

"Janus kinase (JAK) family inhibitor, preparation of same, and applications thereof" was invented by Yong Wu (Jiangsu, China), Yanchun Gong (Jiangsu, China), Wenbin Zhou (Jiangsu, China), Daan Qin (Jiangsu, China), Ya Zhang (Jiangsu, China) and Yongqiang Liu (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A 7-azaindole derivative having the structure of formula (I), a pharmaceutical composition containing the compound of formula (I), and uses of the compound in preparing a medicament for preventing or treating Janus kinase (JAK) family-related d...